| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mutation | 21 | 2025 | 5773 | 1.640 |
Why?
|
| Mitochondrial Proteins | 10 | 2021 | 239 | 1.610 |
Why?
|
| DNA, Mitochondrial | 11 | 2022 | 211 | 1.550 |
Why?
|
| Mitochondrial Encephalomyopathies | 4 | 2020 | 27 | 1.420 |
Why?
|
| Mitochondrial Diseases | 8 | 2022 | 135 | 1.210 |
Why?
|
| Mitochondria | 9 | 2021 | 682 | 1.080 |
Why?
|
| Exome | 10 | 2018 | 1041 | 0.910 |
Why?
|
| Alleles | 15 | 2025 | 1602 | 0.840 |
Why?
|
| 4-Aminobutyrate Transaminase | 3 | 2017 | 7 | 0.830 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 3090 | 0.810 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2024 | 200 | 0.780 |
Why?
|
| Connective Tissue Diseases | 1 | 2021 | 29 | 0.770 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 3 | 2017 | 97 | 0.760 |
Why?
|
| Haplotypes | 6 | 2014 | 519 | 0.760 |
Why?
|
| Brain Diseases | 3 | 2020 | 294 | 0.740 |
Why?
|
| Lymphoma | 1 | 2024 | 321 | 0.720 |
Why?
|
| ATP-Dependent Proteases | 1 | 2020 | 10 | 0.690 |
Why?
|
| Pantothenate Kinase-Associated Neurodegeneration | 1 | 2019 | 2 | 0.680 |
Why?
|
| Pedigree | 15 | 2021 | 1582 | 0.660 |
Why?
|
| Phenotype | 11 | 2021 | 4221 | 0.640 |
Why?
|
| Proteolysis | 1 | 2020 | 164 | 0.640 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 167 | 0.640 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 522 | 0.620 |
Why?
|
| Mutation, Missense | 6 | 2019 | 845 | 0.610 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2018 | 5 | 0.610 |
Why?
|
| Brain Stem | 1 | 2018 | 115 | 0.560 |
Why?
|
| F-Box Proteins | 2 | 2015 | 34 | 0.560 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 142 | 0.550 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 469 | 0.540 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2021 | 2595 | 0.540 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2015 | 3 | 0.520 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2015 | 12 | 0.520 |
Why?
|
| Oxidative Phosphorylation | 5 | 2021 | 93 | 0.510 |
Why?
|
| Infant | 23 | 2021 | 12286 | 0.490 |
Why?
|
| Craniosynostoses | 2 | 2017 | 131 | 0.470 |
Why?
|
| Genetics, Population | 2 | 2019 | 189 | 0.470 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 351 | 0.460 |
Why?
|
| Leigh Disease | 3 | 2019 | 25 | 0.450 |
Why?
|
| Microcephaly | 2 | 2019 | 328 | 0.450 |
Why?
|
| Genetic Association Studies | 5 | 2021 | 760 | 0.450 |
Why?
|
| Precision Medicine | 1 | 2016 | 313 | 0.440 |
Why?
|
| Fibroblasts | 11 | 2021 | 877 | 0.440 |
Why?
|
| Linkage Disequilibrium | 4 | 2006 | 311 | 0.440 |
Why?
|
| RNA Helicases | 1 | 2013 | 63 | 0.420 |
Why?
|
| Ectodermal Dysplasia | 1 | 2012 | 43 | 0.400 |
Why?
|
| Gene Frequency | 5 | 2019 | 714 | 0.400 |
Why?
|
| Child, Preschool | 20 | 2025 | 13819 | 0.390 |
Why?
|
| Consanguinity | 1 | 2012 | 107 | 0.390 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 348 | 0.380 |
Why?
|
| Hyperglycemia | 1 | 2013 | 218 | 0.370 |
Why?
|
| Proteins | 2 | 2015 | 1038 | 0.360 |
Why?
|
| Triglycerides | 1 | 2013 | 561 | 0.350 |
Why?
|
| Dyslipidemias | 1 | 2013 | 227 | 0.350 |
Why?
|
| Gene Pool | 1 | 2009 | 5 | 0.340 |
Why?
|
| Humans | 48 | 2025 | 122998 | 0.340 |
Why?
|
| Male | 34 | 2025 | 59901 | 0.340 |
Why?
|
| Geography | 1 | 2009 | 113 | 0.330 |
Why?
|
| Sequence Analysis, DNA | 4 | 2015 | 1760 | 0.330 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 1845 | 0.330 |
Why?
|
| Neoplasms | 1 | 2024 | 2750 | 0.330 |
Why?
|
| Electron Transport | 3 | 2020 | 54 | 0.320 |
Why?
|
| Female | 32 | 2025 | 65310 | 0.320 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 793 | 0.310 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2024 | 342 | 0.310 |
Why?
|
| Genome, Human | 4 | 2010 | 1266 | 0.300 |
Why?
|
| Homozygote | 4 | 2016 | 533 | 0.300 |
Why?
|
| Base Sequence | 6 | 2018 | 3093 | 0.300 |
Why?
|
| Computational Biology | 3 | 2019 | 799 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 1115 | 0.280 |
Why?
|
| Child | 21 | 2025 | 24144 | 0.270 |
Why?
|
| Neurodegenerative Diseases | 2 | 2020 | 253 | 0.270 |
Why?
|
| Micronesia | 3 | 2013 | 6 | 0.260 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2024 | 74 | 0.250 |
Why?
|
| Databases, Genetic | 2 | 2019 | 471 | 0.240 |
Why?
|
| Infant, Newborn | 11 | 2021 | 8070 | 0.240 |
Why?
|
| Genetics, Medical | 1 | 2006 | 117 | 0.240 |
Why?
|
| Intellectual Disability | 2 | 2025 | 1043 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 849 | 0.240 |
Why?
|
| Europe | 3 | 2015 | 371 | 0.240 |
Why?
|
| Young Adult | 5 | 2024 | 8840 | 0.230 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2025 | 162 | 0.230 |
Why?
|
| Genes, Recessive | 2 | 2015 | 172 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2024 | 26 | 0.230 |
Why?
|
| Learning | 2 | 2019 | 358 | 0.220 |
Why?
|
| Gene Dosage | 2 | 2016 | 441 | 0.220 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 670 | 0.210 |
Why?
|
| Ribonucleotide Reductases | 1 | 2022 | 10 | 0.210 |
Why?
|
| Genes, Neoplasm | 1 | 2002 | 80 | 0.200 |
Why?
|
| Zebrafish | 1 | 2025 | 384 | 0.200 |
Why?
|
| Genetic Variation | 2 | 2016 | 1479 | 0.200 |
Why?
|
| Ubiquinone | 1 | 2021 | 24 | 0.190 |
Why?
|
| Amino Acid Sequence | 6 | 2020 | 2698 | 0.190 |
Why?
|
| Electron Transport Complex IV | 2 | 2018 | 39 | 0.190 |
Why?
|
| Obesity | 1 | 2013 | 2227 | 0.190 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 389 | 0.190 |
Why?
|
| Cerebellar Ataxia | 2 | 2018 | 65 | 0.180 |
Why?
|
| Codon | 1 | 2000 | 97 | 0.180 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2021 | 113 | 0.180 |
Why?
|
| Biopsy | 2 | 2021 | 1239 | 0.180 |
Why?
|
| Fetal Growth Retardation | 2 | 2019 | 222 | 0.180 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2020 | 29 | 0.180 |
Why?
|
| Abnormalities, Multiple | 2 | 2017 | 964 | 0.180 |
Why?
|
| Nucleosides | 2 | 2022 | 17 | 0.180 |
Why?
|
| Adult | 6 | 2024 | 28980 | 0.170 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 3871 | 0.170 |
Why?
|
| NADH Dehydrogenase | 1 | 2019 | 6 | 0.170 |
Why?
|
| Incidence | 2 | 2019 | 3047 | 0.170 |
Why?
|
| Electron Transport Complex I | 1 | 2019 | 31 | 0.170 |
Why?
|
| Dyskeratosis Congenita | 1 | 2019 | 19 | 0.170 |
Why?
|
| Exoribonucleases | 1 | 2019 | 23 | 0.170 |
Why?
|
| Heme | 1 | 2020 | 53 | 0.170 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2019 | 29 | 0.170 |
Why?
|
| Genes, Mitochondrial | 1 | 2019 | 17 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 73 | 0.160 |
Why?
|
| Peptide Elongation Factors | 1 | 2019 | 12 | 0.160 |
Why?
|
| Hydroxymethyl and Formyl Transferases | 1 | 2019 | 5 | 0.160 |
Why?
|
| Genes, Dominant | 2 | 2016 | 243 | 0.160 |
Why?
|
| RNA, Transfer | 1 | 2019 | 70 | 0.160 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 76 | 0.160 |
Why?
|
| Mutagenesis, Insertional | 1 | 2019 | 147 | 0.160 |
Why?
|
| Muscle, Skeletal | 5 | 2018 | 939 | 0.160 |
Why?
|
| Glycoside Hydrolases | 1 | 2018 | 17 | 0.160 |
Why?
|
| Genotype | 3 | 2021 | 2546 | 0.160 |
Why?
|
| Survival Rate | 1 | 2024 | 1993 | 0.160 |
Why?
|
| DNA Copy Number Variations | 2 | 2016 | 940 | 0.150 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2018 | 6 | 0.150 |
Why?
|
| Valine-tRNA Ligase | 1 | 2018 | 2 | 0.150 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 79 | 0.150 |
Why?
|
| Adolescent | 9 | 2025 | 19030 | 0.150 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 21 | 0.150 |
Why?
|
| Hypertrichosis | 1 | 2017 | 5 | 0.150 |
Why?
|
| Antiporters | 1 | 2017 | 32 | 0.150 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2019 | 152 | 0.150 |
Why?
|
| Malate Dehydrogenase | 1 | 2016 | 4 | 0.140 |
Why?
|
| Epilepsy | 1 | 2025 | 859 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 370 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2019 | 383 | 0.140 |
Why?
|
| High-Temperature Requirement A Serine Peptidase 2 | 1 | 2016 | 1 | 0.140 |
Why?
|
| Adenine Nucleotide Translocator 1 | 1 | 2016 | 1 | 0.140 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 126 | 0.140 |
Why?
|
| Acidosis, Lactic | 2 | 2015 | 29 | 0.140 |
Why?
|
| Citric Acid Cycle | 1 | 2016 | 44 | 0.140 |
Why?
|
| Liver Failure, Acute | 1 | 2018 | 87 | 0.140 |
Why?
|
| HLA Antigens | 1 | 2018 | 243 | 0.140 |
Why?
|
| Language Development Disorders | 2 | 2019 | 173 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 327 | 0.130 |
Why?
|
| Memory | 1 | 2019 | 358 | 0.130 |
Why?
|
| Cholestasis | 1 | 2018 | 148 | 0.130 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2015 | 2 | 0.130 |
Why?
|
| Cholestanol | 1 | 2015 | 3 | 0.130 |
Why?
|
| Xanthomatosis | 1 | 2015 | 6 | 0.130 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2015 | 14 | 0.130 |
Why?
|
| Americas | 1 | 2015 | 50 | 0.130 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 35 | 0.130 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 141 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 244 | 0.130 |
Why?
|
| Thiolester Hydrolases | 1 | 2015 | 6 | 0.130 |
Why?
|
| Asia | 1 | 2015 | 107 | 0.130 |
Why?
|
| Africa | 1 | 2015 | 129 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 1695 | 0.130 |
Why?
|
| Protein Biosynthesis | 2 | 2019 | 666 | 0.130 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2016 | 103 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 573 | 0.120 |
Why?
|
| Siblings | 2 | 2015 | 195 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2016 | 83 | 0.120 |
Why?
|
| Genetic Markers | 2 | 2009 | 607 | 0.120 |
Why?
|
| Phylogeny | 3 | 2018 | 684 | 0.120 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2014 | 13 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 871 | 0.120 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 49 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 481 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2014 | 53 | 0.120 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2014 | 44 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 167 | 0.110 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2013 | 8 | 0.110 |
Why?
|
| Multifunctional Enzymes | 1 | 2013 | 5 | 0.110 |
Why?
|
| Nephrolithiasis | 1 | 2013 | 14 | 0.110 |
Why?
|
| Diarrhea | 1 | 2015 | 315 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 695 | 0.110 |
Why?
|
| Chromosome Segregation | 1 | 2013 | 62 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2013 | 31 | 0.110 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2013 | 63 | 0.110 |
Why?
|
| Tetraspanins | 1 | 2013 | 30 | 0.110 |
Why?
|
| Neonatal Screening | 1 | 2015 | 184 | 0.110 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 65 | 0.110 |
Why?
|
| Cataract | 1 | 2015 | 218 | 0.110 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 100 | 0.110 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 647 | 0.110 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 54 | 0.110 |
Why?
|
| Cholesterol | 1 | 2015 | 525 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2019 | 831 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 3283 | 0.100 |
Why?
|
| Biomarkers | 2 | 2019 | 2940 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1267 | 0.100 |
Why?
|
| Protein Transport | 1 | 2013 | 368 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 457 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2013 | 225 | 0.100 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2013 | 372 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2013 | 338 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2016 | 766 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 192 | 0.100 |
Why?
|
| Neuroimaging | 3 | 2021 | 332 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2015 | 1166 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 270 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2013 | 527 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 3510 | 0.090 |
Why?
|
| Population Groups | 1 | 2010 | 30 | 0.090 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 256 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2012 | 262 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 864 | 0.090 |
Why?
|
| Recombination, Genetic | 2 | 2002 | 441 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1801 | 0.080 |
Why?
|
| Age of Onset | 3 | 2016 | 581 | 0.080 |
Why?
|
| Middle Aged | 2 | 2024 | 25931 | 0.080 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 46 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 554 | 0.080 |
Why?
|
| Sex Factors | 1 | 2013 | 1254 | 0.080 |
Why?
|
| Inheritance Patterns | 1 | 2009 | 125 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1313 | 0.080 |
Why?
|
| Microbiota | 1 | 2014 | 392 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2019 | 4705 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2018 | 2577 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2019 | 619 | 0.070 |
Why?
|
| Staphylococcus Phages | 1 | 2006 | 1 | 0.070 |
Why?
|
| Staphylococcus epidermidis | 1 | 2006 | 41 | 0.070 |
Why?
|
| Prevalence | 1 | 2013 | 2394 | 0.070 |
Why?
|
| Adenosine Triphosphate | 2 | 2017 | 286 | 0.070 |
Why?
|
| Genome, Viral | 1 | 2006 | 171 | 0.060 |
Why?
|
| Cell Line | 2 | 2021 | 2779 | 0.060 |
Why?
|
| Animals | 8 | 2025 | 33693 | 0.060 |
Why?
|
| Software | 1 | 2009 | 677 | 0.060 |
Why?
|
| Hypertension | 1 | 2013 | 1277 | 0.060 |
Why?
|
| Drosophila | 2 | 2019 | 766 | 0.060 |
Why?
|
| Cilia | 1 | 2025 | 73 | 0.060 |
Why?
|
| Brain | 4 | 2018 | 2943 | 0.060 |
Why?
|
| Metabolomics | 2 | 2018 | 398 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2482 | 0.050 |
Why?
|
| Prognosis | 3 | 2019 | 4490 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 2002 | 1083 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 170 | 0.050 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2022 | 12 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 92 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2021 | 2820 | 0.050 |
Why?
|
| Pseudogenes | 1 | 2002 | 52 | 0.050 |
Why?
|
| Exons | 2 | 2016 | 795 | 0.050 |
Why?
|
| Ataxia Telangiectasia | 1 | 2000 | 15 | 0.050 |
Why?
|
| Hominidae | 1 | 2000 | 27 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 2048 | 0.050 |
Why?
|
| X Chromosome | 1 | 2002 | 337 | 0.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2000 | 92 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2021 | 164 | 0.040 |
Why?
|
| DNA Replication | 1 | 2022 | 343 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2016 | 3050 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 233 | 0.040 |
Why?
|
| Peptide Elongation Factor Tu | 1 | 2019 | 1 | 0.040 |
Why?
|
| Telomere Shortening | 1 | 2019 | 33 | 0.040 |
Why?
|
| Time Factors | 1 | 2009 | 6198 | 0.040 |
Why?
|
| Penetrance | 1 | 2019 | 103 | 0.040 |
Why?
|
| ADP-Ribosylation | 1 | 2018 | 1 | 0.040 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2018 | 7 | 0.040 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2018 | 23 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 137 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2019 | 284 | 0.040 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2018 | 40 | 0.040 |
Why?
|
| Cutis Laxa | 1 | 2017 | 9 | 0.040 |
Why?
|
| Progeria | 1 | 2017 | 16 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 568 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 45 | 0.040 |
Why?
|
| Valine | 1 | 2018 | 105 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 51 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2018 | 357 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 467 | 0.040 |
Why?
|
| Flumazenil | 1 | 2017 | 4 | 0.040 |
Why?
|
| GABA Modulators | 1 | 2017 | 11 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 113 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 191 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2019 | 835 | 0.040 |
Why?
|
| Mice | 4 | 2019 | 17469 | 0.040 |
Why?
|
| Kinetics | 1 | 2019 | 1313 | 0.040 |
Why?
|
| Malates | 1 | 2016 | 7 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 697 | 0.040 |
Why?
|
| Fumarates | 1 | 2016 | 15 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 185 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2018 | 127 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2016 | 86 | 0.030 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2016 | 7 | 0.030 |
Why?
|
| Serine Proteases | 1 | 2016 | 7 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2016 | 58 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 354 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 227 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 739 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 28 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1997 | 160 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2016 | 223 | 0.030 |
Why?
|
| Growth Disorders | 1 | 2017 | 207 | 0.030 |
Why?
|
| Cell Death | 1 | 2016 | 242 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 92 | 0.030 |
Why?
|
| Metabolome | 1 | 2018 | 294 | 0.030 |
Why?
|
| Facial Asymmetry | 1 | 2015 | 18 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 312 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 179 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2015 | 317 | 0.030 |
Why?
|
| Aged | 1 | 2013 | 19035 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 121 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1741 | 0.030 |
Why?
|
| Canada | 1 | 2015 | 294 | 0.030 |
Why?
|
| Carnitine | 1 | 2015 | 78 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 277 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2019 | 15931 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1569 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 691 | 0.030 |
Why?
|
| Muscle Hypotonia | 1 | 2015 | 185 | 0.030 |
Why?
|
| Space Perception | 1 | 2014 | 62 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 326 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 1113 | 0.030 |
Why?
|
| Algorithms | 1 | 2000 | 1596 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2000 | 3259 | 0.030 |
Why?
|
| Peptides | 1 | 1997 | 798 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 1069 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 119 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2016 | 793 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2017 | 796 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1586 | 0.020 |
Why?
|
| Family | 1 | 2015 | 576 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3710 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1870 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2010 | 55 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1610 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 2027 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2391 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5031 | 0.020 |
Why?
|
| Lysogeny | 1 | 2006 | 10 | 0.020 |
Why?
|
| Virus Assembly | 1 | 2006 | 47 | 0.020 |
Why?
|
| Introns | 1 | 2006 | 302 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2006 | 212 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2533 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 4342 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2002 | 62 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2002 | 671 | 0.010 |
Why?
|
| Trinucleotide Repeats | 1 | 1997 | 109 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 696 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 657 | 0.010 |
Why?
|